Addtech acquires diagnostics company in immunology
Addtech Life Science, a business area in the Addtech Group, has today signed an agreement to acquire all shares outstanding in Immunkemi F&D AB.
Immunkemi distributes diagnostic and research reagents to hospital laboratories, medical schools, universities and the pharmaceutical industry. The company represents leading suppliers in the field of immunology and has revenue of MSEK 10.
Via its subsidiaries Triolab and Bergman Diagnostika, Addtech sells reagents and equipment for hospital laboratories in the entire Nordic Region. With this acquisition the Group increases its exposure to these markets.
The acquisition is estimated to have a marginally positive effect on Addtech's earnings per share during the current financial year. The closing will take place immediately.
Stockholm, 4 January 2008
Addtech AB (publ)
Stockholm, 4 January 2008
Addtech AB (publ)
For further information, contact:
Johan Sjö, President, Addtech AB, +46 8 470 49 03
Göran Brandt, President, Addtech Life Science AB, +46 8 59 41 13 55
Johan Sjö, President, Addtech AB, +46 8 470 49 03
Göran Brandt, President, Addtech Life Science AB, +46 8 59 41 13 55